Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitroglycerine for Microcirculation in Sepsis
NCT00493415Phase 3Completed
- Sponsor
- Frisius Medisch Centrum
- Start
- Jun 2007
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in sepsis and septic shock comparing Nitroglycerine IV with Placebo (2 arms). Primary endpoint: Microvascular Flow Index at 24 hours. Started Jun 2007; status: completed.
02
Drugs
nitroglycerin
03
Conditions
sepsisseptic shock
Beyond the preview
Go deeper on NCT00493415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00493415.